Disease Markers / 2014 / Article / Tab 1

Clinical Study

Neutrophil-to-Lymphocyte Ratio as a Predictor of Response to Peginterferon plus Ribavirin Therapy for Chronic Hepatitis C

Table 1

Baseline characteristics of the study population.

Variables

Age (mean ± SD) (yr)54.3 ± 11.1
Gender (male/female)316/286
rs12979860 (CC/CT or TT)422/67
Cirrhosis (%)91 (15%)
DM (%)103 (17%)
BMI (kg/m2)24.7 ± 3.7
Log HCV-RNA (IU/mL)5.4 ± 1.0
Genotype 1/2/3/5/6263/297/9/1/14
WBC (103/μL)5.8 ± 1.7
N-L ratio1.60 ± 0.89
Platelet (104/μL)17.6 ± 5.9

Available in 489 (81%) and 584 (97%) of patients.
DM: diabetes mellitus; BMI: body mass index; RVR: rapid virological response; WBC: white cell count; N-L ratio: neutrophil-lymphocyte ratio.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.